PRA’s Remote Patient Monitoring Platform Selected by Merck KGaA, Darmstadt, Germany to Work in Combination with its Human Growth Hormone Treatment System
RALEIGH, N.C. , April 7 (Korea Bizwire) — PRA Health Sciences (NASDAQ: PRAH) announced today that Merck KGaA, Darmstadt, Germany, known in the United States as EMD Serono, selected PRA’s remote patient monitoring platform to work in combination with its human growth hormone (HGH) treatment system. Under this agreement, PRA’s remote patient monitoring platform backs [...]